Stock DMA DIAMEDICA INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar DiaMedica Inc. Toronto S.E.

Equities

DMA

CA25253T1075

End-of-day quote Toronto S.E.
Other stock markets
- CAD - Intraday chart for DiaMedica Inc.
06-27 Transcript : DiaMedica Therapeutics Inc. - Special Call
06-26 DiaMedica Therapeutics Inc. Plans to Expand Its Clinical Trials into Preeclampsia CI

Chart calendar DiaMedica Inc.

2384e3a7d18078da68d0e7c1.9znU7ryw-OF9q1-6wWtHnjXZGlaRlu8hgxho5HRTGqE.kmbin8-Jt5U54irSkQgs_H--XBXorqxC1n8YhRsyWc-ASYLe-PTV2S7bBg~4f5908d366f5b5717760afe5843b6612

Upcoming events on DiaMedica Inc.

28/07/2024 Investor Meeting - Key Opinion Leader
12/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
05/02/2025 International Stroke Conference
24/03/2025 Q4 2024 Earnings Release (Projected)
18/05/2025 Q1 2025 Earnings Release (Projected)

Past events on DiaMedica Inc.

27/06/2024 13:00 Business Update Call
28/05/2024 Craig Hallum Institutional Investor Conference
22/05/2024 15:00 Annual General Meeting
09/05/2024 13:00 Q1 2024 Earnings Call
08/05/2024 21:30 Q1 2024 Earnings Release
20/03/2024 12:00 Q4 2023 Earnings Call
19/03/2024 20:15 Q4 2023 Earnings Release
12/02/2024 Oppenheimer Healthcare Life Sciences Conference
06/02/2024 International Stroke Conference
15/11/2023 Craig-Hallum Alpha Select Conference
14/11/2023 13:00 Q3 2023 Earnings Call
13/11/2023 21:28 Q3 2023 Earnings Release
15/08/2023 13:00 Q2 2023 Earnings Call
14/08/2023 21:13 Q2 2023 Earnings Release
27/07/2023 AAN Summer Conference
30/05/2023 Craig-Hallum Institutional Investor Conference
17/05/2023 19:00 Annual General Meeting
16/05/2023 13:00 Q1 2023 Earnings Call
15/05/2023 21:28 Q1 2023 Earnings Release
29/03/2023 13:00 Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CAD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million CAD		Released
Forecast
Spread 		-16,8
-14,5
-15.76%		-13,7
-13,7
0.31%		0,00
0,00
- 		0,00
0,00
- 		-28,8
-28,5
-0.96%
-39,0

EBIT
Million CAD		Released
Forecast
Spread 		-16,9
-15,7
-7.72%		-16,1
-15,3
-5.18%		-17,4
-19,3
9.57%		-19,1
-18,5
-2.95%		-28,9
-28,7
-0.58%
-37,3

Earnings before Tax (EBT)
Million CAD		Released
Forecast
Spread 		-15,4
-14,7
-5.04%		-15,5
-14,5
-6.67%		-17,3
-18,9
8.31%		-18,6
-18,3
-1.59%		-26,2
-26,7
1.72%
-35,7

Net income
Million CAD		Released
Forecast
Spread 		-15,5
-14,8
-4.94%		-15,5
-14,6
-6.8%		-17,3
-19,2
9.45%		-18,6
-18,4
-1.3%		-26,3
-26,7
1.69%
-35,7

EPS
USD		Released
Forecast
Spread 		-0,89
-0,93
4.64%		-0,78
-0,72
-8.03%		-0,65
-0,73
10.96%		-0,52
-0,52
0%		-0,60
-0,61
0.83%
-0,67

Announcement Date23/03/2010/03/2114/03/2228/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million CAD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBITDA
Million CAD		Released
Forecast
Spread











-7,43
-6,52
-14.01%		-6,37
-7,10
10.23%		-7,10
-6,33
-12.06%		-7,92
-7,41
-6.95%		-7,87
-7,93
0.78%
-9,31


-10,7


-11,4


-11,5


-12,9

EBIT
Million CAD		Released
Forecast
Spread 		-4,54
-6,67
31.96%		-4,29
-6,33
32.16%		-4,21
-5,33
21.03%		-5,41
-5,04
-7.44%		-7,45
-5,95
-25.24%		-6,38
-7,00
8.85%		-7,11
-6,51
-9.21%		-7,93
-7,68
-3.29%		-7,88
-8,55
7.8%
-8,87


-10,0


-10,5


-11,5


-12,9

Earnings before Tax (EBT)
Million CAD		Released
Forecast
Spread 		-4,49
-6,67
32.64%		-4,28
-6,68
36.02%		-4,11
-5,45
24.58%		-5,10
-4,98
-2.33%		-7,11
-5,81
-22.23%		-6,02
-6,87
12.42%		-6,15
-6,38
3.48%		-6,97
-7,36
5.27%		-7,06
-8,22
14.16%
-8,60


-9,76


-10,3


-11,5


-12,9

Net income
Million CAD		Released
Forecast
Spread 		-4,50
-6,68
32.61%		-4,29
-6,33
32.28%		-4,12
-5,33
22.77%		-5,11
-4,99
-2.34%		-7,12
-5,81
-22.39%		-6,03
-6,92
12.84%		-6,16
-6,38
3.33%		-7,00
-7,36
4.89%		-7,07
-8,22
14.04%
-8,60


-9,76


-10,3


-11,5


-12,9

EPS
USD		Released
Forecast
Spread 		-0,13
-0,20
35%		-0,13
-0,18
27.78%		-0,12
-0,15
18.64%		-0,14
-0,14
0%		-0,20
-0,16
-25%		-0,16
-0,18
9.44%		-0,12
-0,13
5.27%		-0,14
-0,14
0%		-0,14
-0,16
10.64%
-0,16


-0,18


-0,19


-0,22


-0,25

Announcement Date04/05/2210/08/2209/11/2228/03/2315/05/2314/08/2313/11/2319/03/2408/05/24-----

Upcoming sector events for DiaMedica Inc.

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for DiaMedica Inc.

05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. DMAC Stock
  4. DMA Stock
  5. Calendar DiaMedica Inc.